| Financial Year |
March 31 2023 |
| Monetary Funds |
170,075,464.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
66,162,869.40 |
| Accounts Receivable |
502,323,648.16 |
| Advances to Suppliers |
35,221,077.74 |
| Other Receivables |
87,879,885.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
211,298,427.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,352,541.21 |
| Total Current Assets |
1,706,152,819.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,628,383.97 |
| Investment Properties |
-- |
| Fixed Assetes |
460,443,359.32 |
| Under-construction Projects |
29,512,886.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,393,940.84 |
| R&D expenses |
-- |
| Goodwill |
42,357,720.84 |
| Long-Term Deferred and Prepaid Expenses |
9,300,645.33 |
| Deferred Income Tax Assets |
6,514,134.40 |
| Other Non-Current Assets |
301,695,433.79 |
| Sub-Total of Non-Current Assets |
1,071,270,644.49 |
| Total Assets |
2,777,423,464.11 |
| Short-Term Loans |
400,113,467.59 |
| Trading Financial liabilities |
-- |
| Notes Payable |
180,965,384.90 |
| Accounts Payable |
649,130,072.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,483,686.58 |
| Taxes Payable |
4,907,967.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,989,731.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
90,653,683.05 |
| Other Current Liabilities |
44,743,081.91 |
| Sub-Total of Current Liabilities |
1,462,296,107.78 |
| Long-term Loans |
37,489,500.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
17,810,521.89 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
67,056,178.62 |
| Total Liabilities |
1,529,352,286.40 |
| Paid-In Capital(Or Share Stock) |
318,006,876.00 |
| Capital Surplus |
696,824,291.94 |
| Surplus Reserve |
39,772,459.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
196,377,835.47 |
| Minority Stockholder's Interest |
-2,884,956.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,250,956,133.94 |
| Owner's Equity（Stockholder's Equity） |
1,248,071,177.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,777,423,464.11 |
